Establishing a correctly characterized molecule in early drug development

The physical properties of a solid active pharmaceutical ingredient (API) largely determine the crystallization process used for isolation, purification and form control, and also guide the development of an effective formulation. Understanding of the relevant solid-state properties and solid-liquid equilibria are therefore central to both chemical process and product development. In addition, it is essential to understand interactions between the API and excipients used in a formulation in order to capture any incompatibilities early in development and mitigate for these.

In this webinar you will learn from our experts Dr. Gordon Hutton, Dr. Matthew J Jones, and Dr. Kevin Kane on:

Related Sites

Additional Resources